Kennedy Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.92M | Buy |
27,955
+22,133
| +380% | +$2.31M | 0.07% | 380 |
|
|
2025
Q1 | $679K | Sell |
5,822
-32,119
| -85% | -$3.75M | 0.02% | 558 |
|
|
2024
Q4 | $3.21M | Buy |
37,941
+18,510
| +95% | +$1.57M | 0.07% | 413 |
|
|
2024
Q3 | $1.75M | Sell |
19,431
-1,184
| -6% | -$106K | 0.04% | 535 |
|
|
2024
Q2 | $1.66M | Buy |
20,615
+1,132
| +6% | +$91.1K | 0.04% | 533 |
|
|
2024
Q1 | $1.55M | Buy |
19,483
+6,136
| +46% | +$490K | 0.03% | 563 |
|
|
2023
Q4 | $1.06M | Buy |
13,347
+1,255
| +10% | +$99.9K | 0.02% | 580 |
|
|
2023
Q3 | $845K | Buy |
12,092
+2,354
| +24% | +$165K | 0.02% | 580 |
|
|
2023
Q2 | $700K | Buy |
+9,738
| New | +$700K | 0.02% | 580 |
|